- Category Marryalyan
- DATE 25 Feb 2025
Cancer Symptom Trials and Palliative Care Clinical Studies Collaborative
February 2025

PaCCSC & CST Research Forum 2025
The Science behind the Art of care: Clinical trials in cancer symptoms and palliative care
27-28 March 2025 | ICC, Sydney
We’re excited to invite you to the PaCCSC & CST Research Forum 2025, where we’ll explore the scientific foundations that inform best practices in cancer symptom management and palliative care.
We are thrilled to welcome three international keynote speakers to the forum:
-
- Professor William Dale, Geriatric Medicine, USA
- Professor Catherine Walshe, Palliative Care, UK
- Professor Steve Pantilat, Palliative Care, USA
This event is for researchers, healthcare professionals and consumers with experience or interest in palliative care or cancer symptom management research.
We invite you to take this opportunity to connect with leading experts and build your networks in palliative care and cancer symptom management research.
Register now
Email enquiries to [email protected]
Expressions of interest – Join a PaCCSC & CST Symptom Node Subcommittee
Help shape the future of palliative care and cancer symptom management
Researchers, clinicians and consumers with an interest in palliative care and/or cancer symptom management are invited to express interest in joining a PaCCSC & CST Symptom Node Subcommittee
Our seven Symptom Node Subcommittees (SNSCs) each lead a dedicated research program focused on a specific symptom:
-
- Appetite and cachexia
- Breathlessness and sleep
- Cognitive and neurological disorders
- Fatigue
- Gut dysfunction
- Nausea
- Pain
This is an excellent opportunity to extend your personal research profile as part of a collaborative research team, while contributing to better quality-of-life outcomes for patients and families.
Hannah Wardill, Chair, Gut Dysfunction Symptom Node SubCommittee
We'd love to hear from you if:
-
- you have an interest in collaborating on a research program investigating one or more symptoms and its impacts on people with cancer or in palliative care
- have capacity to be committed and engaged to support the work of the node.
Commitment
Term of membership: two years Meeting schedule: quarterly 1-hour meetings. For questions or to express interest in joining an SNSC, please email [email protected]
IMPACCT Rapid Program
The IMPACCT Rapid Program is a collaborative international quality improvement program that studies the prospective use of medications and non-pharmacological interventions commonly used in palliative care and cancer symptom management.
Participating in the program provides an opportunity to develop the capacity and research capabilities of you and your staff who may not otherwise have the opportunity to engage in research.
Adult series
Pancreatic Enzyme Replacement Therapy (PERT) for pancreatic cancer – series 53
The PERT for pancreatic cancer Rapid series is open for recruitment. This study aims to explore clinicians’ prescribing practices and evaluate the efficacy and safety of PERT for people with pancreatic cancer. PERT is a biological medication administered in capsule form to treat pancreatic exocrine insufficient (PEI) as it aids digestion.
Research suggests that PERT is well tolerated and helps with symptom management, weight stabilisations, toleration of oncology treatments and even survival. However, published literature indicates that prescribing rates are low globally among clinicians treating people with pancreatic cancer.
Paediatric series
Ketamine for cancer-related mucositis pain – series 42
In this series, we are seeking to establish the broad utility and toxicity of ketamine for children with chronic non-cancer pain and cancer pain in real-life situations.
Ketamine is widely used for paediatric general and regional anaesthesia, procedural sedation, as an adjunct to opioid analgesia, and as a low-dose continuous infusion for the treatment of both acute and complex pain.
If you can help us to collect data to improve the available evidence about the effectiveness of ketamine for children with cancer-related mucositis pain, please get in touch.
To express interest in participating in these series or to learn more about other series in the IMPACCT Rapid Program, visit uts.edu.au/rapid or email [email protected]
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 3 days ago
Cancer Survivorship 2025 - Day 1 of thought provoking presentations and stimulating discussions around important survivorship topics including financial toxicity, living with metastatic cancer, and providing tailored person-centred care. Bring on Day 2! #Surv25
Read More >
COSAoncology 4 days ago
Our 2025 National Cancer Survivorship Conference begins tomorrow. Be prepared for an exciting program showcasing innovations in survivorship care, research, advocacy and policy. Plus opportunities to meet, mingle and collaborate. bit.ly/3F6okgT #Surv25
Read More >
COSAoncology 11 days ago
The theme for COSA-IPOS 2025 in Adelaide in November is 'Optimising care, optimising outcomes – Partnering to improve outcomes for all'. For consideration in the program, submit your abstract by Friday 6 June 2025. For details: bit.ly/3XiOu6x #COSA25
Read More >
COSAoncology 12 days ago
Our February member newsletter is out now. Check your inbox or log into your COSA member account for the latest COSA and COSA member news including events, new resources, journal articles and more bit.ly/4hRcx4I
Read More >
COSAoncology one month ago
Read the latest news from COSA and COSA members in our January eNews. Check your inbox or login to your COSA member account to view now: bit.ly/3E9PrHm
Read More >
COSAoncology one month ago
Cancer Survivorship 2025 will showcase innovation in survivorship care, research, advocacy and policy. Health professionals and public are encouraged to attend. Earlybird registration closes this Friday 17 January. View the program and register at bit.ly/3sai0LG #Surv25
Read More >
COSAoncology 3 months ago
RT by @cosaoncology: Disability and cancer care – We can do both! - @ShonaEdwards2 @CVSAinfo @COSAoncology oncodaily.com/blog/198335 #Cancer #CancerCare #DisabilityCare #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
Read More >
COSAoncology 3 months ago
RT by @cosaoncology: Great to see how research has expanded in #AYA psychosocial care 🙌🏻 Dr Ursula Sansom-Daly @usansomdaly presents the updated, evidence-based @COSAoncology Guidelines for the Psychosocial Management of AYAs with #cancer - coming soon! Learn more: cosa.org.au/about/projects… #AYACSM
Read More >
COSAoncology 3 months ago
Read the latest news from COSA and COSA members in our November eNewsletter. Check your inbox or login to your COSA member account to view now: bit.ly/4cI0nc3
Read More >
COSAoncology 3 months ago
Congratulations David Thomas for recognition of your leadership and groundbreaking work in genomics in cancer care. And congratulations to all the recipients of the 2024 Premier's Awards for Outstanding Cancer Research. #cancerNSWawards
Read More >